Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting

Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting

LUGANO, Switzerland and San Diego, USA, December 3, 2018: Helsinn Group, a Swiss pharmaceutical

Thailand National Day

On behalf of the Government of the United States of America, I offer my sincerest and warmest wishes to the Kingdom of Thailand on your National Day. This year marked the 200-year anniversary of the historic U.S.-Thai friendship that has …